As of 2025-12-29, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -118.11 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 170.00 GBP, the upside of Faron Pharmaceuticals Oy is -169.47%.
Based on its market price of 170.00 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 169.47%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -118.11 - -118.11 | -118.11 | -169.47% |
| P/E | (58.11) - (42.52) | (47.83) | -128.1% |
| DDM - Stable | (182.76) - (750.66) | (466.71) | -374.5% |
| DDM - Multi | (137.82) - (457.55) | (213.89) | -225.8% |
| Market Cap (mil) | 194.23 |
| Beta | -0.18 |
| Outstanding shares (mil) | 1.14 |
| Enterprise Value (mil) | 201.97 |
| Market risk premium | 5.98% |
| Cost of Equity | 9.94% |
| Cost of Debt | 5.00% |
| WACC | 9.68% |